Cost Effectiveness of Gene Expression Profiling for Early Stage Breast Cancer

Publication Name: Cancer

Author(s): Mo Yang, MS; Suja Rajan, PhD; and Amalia M. Issa, PhD, MPH

BACKGROUND: Gene expression profiling (GEP) is being used increasingly for risk stratification to identify women with lymph nodenegative, estrogen receptor-positive, early stage breast cancer who are most likely to benefit from adjuvant chemotherapy. The authors of this report evaluated the … Continued

Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Population Sample of Women With Breast Cancer

Publication Name: Journal of the National Cancer Institute

Author(s): Michael J. Hassett , A. James O’Malley , Juliana R. Pakes , Joseph P. Newhouse , Craig C. Earle

Background: The number, nature, and costs of serious adverse effects experienced by younger women receiving chemotherapy for breast cancer outside of clinical trials are unknown. Methods: From a database of medical claims made by individuals with employer-provided health insurance between … Continued